Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Abstract The myocardin-related transcription factor/serum response factor (MRTF/SRF) pathway represents a promising therapeutic target to prevent fibrosis. We have tested the effects of new pharmacological inhibitors of MRTF/SRF signalling in a preclinical model of fibrosis. CCG-222740, a novel MRTF...
Guardado en:
Autores principales: | Cynthia Yu-Wai-Man, Bradley Spencer-Dene, Richard M. H. Lee, Kim Hutchings, Erika M. Lisabeth, Richard Treisman, Maryse Bailly, Scott D. Larsen, Richard R. Neubig, Peng T. Khaw |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0d09e6ee5ac462a80dbec12fafe4e2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nuclear-capture of endosomes depletes nuclear G-actin to promote SRF/MRTF activation and cancer cell invasion
por: Sergi Marco, et al.
Publicado: (2021) -
Cyclase-associated protein 2 (CAP2) controls MRTF-A localization and SRF activity in mouse embryonic fibroblasts
por: Lara-Jane Kepser, et al.
Publicado: (2021) -
STARS is essential to maintain cardiac development and function in vivo via a SRF pathway.
por: Nelson W Chong, et al.
Publicado: (2012) -
Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs
por: Takashi Ikeda, et al.
Publicado: (2018) -
Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology
por: Marisa Kaneda, et al.
Publicado: (2018)